These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 8294096

  • 1. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, Felts K, Sorge JA.
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [Abstract] [Full Text] [Related]

  • 2. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH.
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [Abstract] [Full Text] [Related]

  • 3. Nuclear ploidy of normal and neoplastic hepatocytes from woodchuck hepatitis virus-infected and uninfected woodchucks.
    Cullen JM, Linzey DW, Gebhard DH.
    Hepatology; 1994 May; 19(5):1072-8. PubMed ID: 8175128
    [Abstract] [Full Text] [Related]

  • 4. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR, Finegold MJ, Smith B, Slagle BL, DeMayo JL, Shen RF, Woo SL, Butel JS.
    Cancer Res; 1989 Nov 01; 49(21):6108-17. PubMed ID: 2551499
    [Abstract] [Full Text] [Related]

  • 5. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C, Derose PB.
    Mod Pathol; 1994 Jan 01; 7(1):31-6. PubMed ID: 8159650
    [Abstract] [Full Text] [Related]

  • 6. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
    Francalanci P, Santorelli FM, Saccani S, Bonetti MF, Medicina D, Coni P, Faa G, Callea F.
    Liver Int; 2009 Nov 01; 29(10):1593-6. PubMed ID: 19744266
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Pediatr Res; 2006 Aug 01; 60(2):233-8. PubMed ID: 16864711
    [Abstract] [Full Text] [Related]

  • 9. Transgenic mouse models of hepatocellular carcinoma.
    Gordon JW.
    Hepatology; 1994 Feb 01; 19(2):538-9. PubMed ID: 8294111
    [No Abstract] [Full Text] [Related]

  • 10. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ, Meijer JW, van den Elshout FJ, de Vries RA.
    Ned Tijdschr Geneeskd; 2000 Nov 18; 144(47):2269-72. PubMed ID: 11109473
    [Abstract] [Full Text] [Related]

  • 11. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.
    Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K.
    Hepatology; 1994 Apr 18; 19(4):810-9. PubMed ID: 8138251
    [Abstract] [Full Text] [Related]

  • 12. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 18; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 13. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
    Dunsford HA, Sell S, Chisari FV.
    Cancer Res; 1990 Jun 01; 50(11):3400-7. PubMed ID: 1692259
    [Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 01; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 15. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
    Rubel LR, Ishak KG, Benjamin SB, Knuff TE.
    Arch Pathol Lab Med; 1982 Dec 01; 106(13):678-81. PubMed ID: 6291490
    [Abstract] [Full Text] [Related]

  • 16. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, Korenaga M, Xiao SY, Weinman SA, Lemon SM, Sakaida I, Okita K.
    Gastroenterology; 2006 Jun 01; 130(7):2087-98. PubMed ID: 16762631
    [Abstract] [Full Text] [Related]

  • 17. The etiology of underlying liver lesions in 70 autopsied cases of hepatocellular carcinoma.
    Horváth A, Slugen I, Ferák I, Hruskovic I, Plesko I, Ondrias F.
    Neoplasma; 1985 Jun 01; 32(5):629-37. PubMed ID: 2999628
    [Abstract] [Full Text] [Related]

  • 18. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.
    Rudnick DA, Perlmutter DH.
    Hepatology; 2005 Sep 01; 42(3):514-21. PubMed ID: 16044402
    [Abstract] [Full Text] [Related]

  • 19. Development of liver tumors in transforming growth factor alpha transgenic mice.
    Lee GH, Merlino G, Fausto N.
    Cancer Res; 1992 Oct 01; 52(19):5162-70. PubMed ID: 1327502
    [Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 01; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.